SurgiVision has received FDA clearance for its MRI-Compatible SmartFlow Cannula, for use with the previously covered ClearPoint system (pictured above).
From the press release:
The SmartFlow cannula is an MRI-compatible injection and aspiration cannula for use in the brain. The SmartFlow cannula is compatible with SurgiVision’s ClearPoint® system. Using the new SmartFlow cannula with the ClearPoint system, neurosurgeons can select a neurological target, navigate the SmartFlow cannula to the target and observe the delivery of the therapeutic agent, all under intra-procedural MRI guidance. Other features of the SmartFlow cannula include a multi-step tip design to help prevent reflux along the cannula shaft.
“The medical community is continuing to find therapeutic agents that hold great promise in treating various CNS disorders, however many of these agents will require precision delivery, direct into a small neuro target,” said Kimble Jenkins, CEO of SurgiVision. “It is our hope that SurgiVision’s expanding range of products in interventional MRI could help fill this need and lead to better therapies for patients.”
At the same time, SurgiVision has also announced a collaboration with Brainlab, to bring the ClearPoint product line to that company’s iMRI interventional MRI suite. Aim of that collaboration is to enable local delivery of drugs and other therapeutic agents to precision targets in the brain under MRI guidance, in brain disorders such as Parkinson disease and malignant brain tumors.
Press releases: SurgiVision MRI-Compatible SmartFlow Cannula Receives FDA Clearance…, Brainlab and SurgiVision Announce Strategic Alliance in MRI-guided Drug Delivery and Other Interventional MRI Technologies in Neurosurgery…